Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

MR-guided focused ultrasound may effectively control essential tremor

In a presentation at the Congress of Neurological Surgeons today, University of Virginia neurosurgeon W. Jeffrey Elias, MD reported that preliminary results of a pilot clinical trial indicate that MR-guided focused ultrasound has the potential to safely and effectively control essential tremor (ET), a common neurological condition that affects 10 million Americans.

4 Oct 2011

Strong connection between preterm birth and risk of epilepsy

Being born prematurely may increase your risk of developing epilepsy as an adult, according to a new study published in the October 4, 2011, issue of Neurology, the medical journal of the American Academy of Neurology.

4 Oct 2011

TAU researcher implants robotic cerebellum to repair motor function

With new cutting-edge technology aimed at providing amputees with robotic limbs, a Tel Aviv University researcher has successfully implanted a robotic cerebellum into the skull of a rodent with brain damage, restoring its capacity for movement.

4 Oct 2011

Largest prospective study of MRI in patients with implanted devices

Magnetic Resonance Imaging (MRI), an important diagnostic test, has traditionally been off limits to more than 2 million people in the United States who have an implanted pacemaker to regulate heart rhythms or an implanted defibrillator to prevent sudden cardiac death.

4 Oct 2011

Loyola's SSOM receives $100,000 grant for research into pediatric leukemia

Loyola University Chicago Stritch School of Medicine (SSOM) today received a $100,000 grant to support research to treat an aggressive form of pediatric leukemia.

4 Oct 2011

Researchers identify new enzyme function that may protect against anemia

Researchers at St. Michael's Hospital have discovered a new function for an enzyme that may protect against organ injury and death from anemia.

4 Oct 2011

AMRI announces final results from ALB-127158(a) Phase I clinical studies on obesity

AMRI announced today the final results from its Phase I clinical studies on its novel MCH1 receptor antagonist, ALB-127158(a) during the 29th Annual Scientific Meeting of the Obesity Society in Orlando, Fla.

4 Oct 2011

Post Acute Medical acquires Hill Country Specialty Hospital

Post Acute Medical today announced the purchase and immediate operation of 40-bed Hill Country Specialty Hospital.

3 Oct 2011

Elekta sells Anatomic Pathology Information System business to Sunquest

Elekta AB today announced it has divested its Anatomic Pathology Information System business, marketed under the brand name PowerPath, a software line that manages workflow for laboratories offering surgical pathology, cytology, dermatopathology and autopsy services.

From Elekta 3 Oct 2011

General anesthesia linked to learning disabilities in children

Every year millions of babies and toddlers receive general anesthesia for procedures ranging from hernia repair to ear surgery. Now, researchers at Mayo Clinic in Rochester have found a link among children undergoing multiple surgeries requiring general anesthesia before age 2 and learning disabilities later in childhood.

3 Oct 2011

FDA clears Nucletron's new VCMC Applicator for gynecologic cancers

During the first day of the annual conference for the American Society for Radiation Oncology (ASTRO) in Miami, Nucletron, an Elekta company, today announced that it has received FDA 510(k) clearance for its new Vaginal CT/MR Multi Channel (VCMC) Applicator, offering a brachytherapy solution that enables very precise dose delivery for gynecologic cancers.

From Elekta 3 Oct 2011

First clinical implementation of RayStation at MGH

RaySearch Laboratories AB announces that the first cancer patient has been treated using a treatment plan created with RaySearch's treatment planning system RayStation. The treatment was carried out at the Massachusetts General Hospital Radiation Oncology Department.

From Elekta 3 Oct 2011

Tight blood sugar control fails to improve memory in diabetics

A new study has shown that those with type 2 diabetes do not show slowing of the decline in thinking skills with intense blood sugar control. In fact such intense therapy raises risk of death.

2 Oct 2011

Third Annual Walk for Lupus Now! to take place in Richmond on Oct. 29

Purple passion will cap a month of pink ribbons—raising funds and awareness for people with lupus, a still-unknown disease. More than 1,000 people with lupus, their families, friends and co-workers dressed in purple will carry butterflies in the Third Annual Walk for Lupus Now! Richmond on Saturday, Oct. 29 at 3:00 p.m.

1 Oct 2011

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Columbia University will award the 2011 Louisa Gross Horwitz Prize to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their work on the molecular basis of circadian rhythms, the first demonstration of a molecular mechanism for behavior.

1 Oct 2011

Planned clinical trial of Adeona's zinc-based therapy for ALS patients to be featured at ALS Summit

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that its planned clinical trial of the Company's proprietary zinc-based therapy for patients suffering from amyotrophic lateral sclerosis, also known as Lou Gehrig's Disease, will be featured during the Hot Topics session at the 2011 California ALS Research Summit on Saturday, October 1, 2011.

1 Oct 2011

UAB Comprehensive Cancer Center receives NCI grant to renew support for cancer research program

The University of Alabama at Birmingham Comprehensive Cancer Center has received a five-year, $27.5 million Cancer Center Support Grant from the National Cancer Institute to renew support for its cancer research program through 2016.

1 Oct 2011

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Pfizer Inc. today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of invasive aspergillosis, a life-threatening invasive fungal infection that can develop as a complication in patients with compromised immune systems.

1 Oct 2011

Study calls for review of current treatment strategies, more research into stroke prevention

Doctors are underutilising crucial medication to prevent deadly strokes in those with a common type of heart condition, new research says, leading to fresh calls for a review of current treatment strategies and more research into stroke prevention.

1 Oct 2011